However, perhaps Liu Meng did not expect Ruan Liuzheng to prepare so thoroughly and deeply.
"Director, the patient's source iPSC, in terms of cellular and gene therapy, has significant advantages. To use iPSC to treat skin diseases, it first needs to be effectively differentiated into the main cells of the skin, which are keratinocytes and fibroblasts."
"These cells can be used to study and treat wound healing and other degenerative skin diseases, and they can also provide new tissue engineering therapies for hair loss."
Ruan Liuzheng spoke eloquently. It was evident that she truly understood this highly convoluted knowledge, rather than merely memorizing it.
As she spoke, the eyes of several advanced training and regulatory doctors widened!
Originally, everyone was on the same starting line, and it was normal if no one could answer a question.
But Ruan Liuzheng's reply highlighted the insufficient knowledge reserves of the others.
"Dr. Ruan, is there anything else?"
